Chronic pulmonary aspergillosis (CPA) is a slow-progressing pulmonary fungal infectious disease caused by Aspergillus. Aspergillus IgG and IgM are now considered to be valuable biomarkers in CPA diagnosis.
It is recommended in:Symptoms such as allergic reactions like wheezing and coughing, especially in people suffering from asthma or cystic fibrosis. This infection can spread via the bloodstream and affect the lungs, kidneys, heart and brain.
The Aspergillus Antibody IgM test: Increased and elevated levels of IgG antibodies to are consistent with the diagnosis of aspergillosis. These antibodies may persist even after successful therapy. Increased levels of IgM antibodies to Aspergillus indicate current infection. is a causative agent of hypersensitivity pneumonitis, invasive lung disease, and allergic bronchopulmonary disease.The Aspergillus IgM is a laboratory test performed on a patient’s blood. Aspergillus IgG and IgM are now considered to be valuable biomarkers in CPA diagnosis.
The Aspergillus Antibody IgM test is prescribed by your doctor after completing the assessment of your condition.
Positive / Negative
This test requires a blood sample.
This test can be taken at any time during the day.
Fasting is not required for this test.
There are no specific precautions for this test.
Copyright © 2024 Medtotes Pvt Ltd, All Right Reserved.